KFA
NWBO

Kelleher Financial Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Kelleher Financial Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.3K Buy
+200,000
New +$41.3K 0.01% 399

Other funds holding NWBO

VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
ME
McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return

Kelleher Financial Advisors's NWBO Position: Q1 2026 in Review

Kelleher Financial Advisors opened a new position in Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2026: 200,000 shares worth $41.3K. The stake represents 0.01% of the portfolio and ranks #399 among its holdings.

8 funds tracked by Wall St. Rank hold NWBO as of Q1 2026.

  • Kelleher Financial Advisors held 200,000 shares of Northwest Biotherapeutics, Inc. Common stock worth $41.3K as of Q1 2026.
  • Northwest Biotherapeutics, Inc. Common stock was a new Kelleher Financial Advisors position in Q1 2026.
  • Northwest Biotherapeutics, Inc. Common stock made up 0.01% of Kelleher Financial Advisors's portfolio in Q1 2026, its #399 holding.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2026.

Based on Kelleher Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.